| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/MMY/MYW009 |
| P698 | PubMed publication ID | 27001670 |
| P50 | author | Eleftherios Mylonakis | Q56769876 |
| P2093 | author name string | Weiping Chen | |
| Xiangdong Zhang | |||
| Jian Zou | |||
| Song Zhu | |||
| Dimitrios Farmakiotis | |||
| Jingdong Yan | |||
| Ruilan Chen | |||
| Xiaojiang Tan | |||
| Dongxing Yan | |||
| P2860 | cites work | Candida colonization and subsequent infections in critically ill surgical patients | Q24535524 |
| Microbial synergy via an ethanol-triggered pathway | Q27938765 | ||
| Developing a new, national approach to surveillance for ventilator-associated events: executive summary | Q30409101 | ||
| The warmer the weather, the more gram-negative bacteria - impact of temperature on clinical isolates in intensive care units | Q31153494 | ||
| Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans | Q33369708 | ||
| Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia | Q34042432 | ||
| Microbiology, resistance patterns, and risk factors of mortality in ventilator-associated bacterial pneumonia in a Northern Thai tertiary-care university based general surgical intensive care unit | Q34075262 | ||
| Epidemiology of Candida species infections in critically ill non-immunosuppressed patients | Q34273626 | ||
| Drug-resistant Candida glabrata infection in cancer patients | Q34426755 | ||
| Candida biofilms and their role in infection | Q35044563 | ||
| Nosocomial and ventilator-associated pneumonia in a community hospital intensive care unit: a retrospective review and analysis | Q35146116 | ||
| The role of Candida albicans SPT20 in filamentation, biofilm formation and pathogenesis | Q35147589 | ||
| Pulmonary infiltrates in the non-HIV-infected immunocompromised patient: etiologies, diagnostic strategies, and outcomes | Q35626675 | ||
| Fungal-bacterial interactions and their relevance in health | Q35738043 | ||
| Diagnosis of ventilator-associated pneumonia: a systematic review of the literature | Q36749132 | ||
| Phenotypic and molecular characterization of Acinetobacter baumannii clinical isolates from nosocomial outbreaks in Los Angeles County, California | Q36845404 | ||
| Acinetobacter baumannii: an emerging multidrug-resistant threat | Q37202840 | ||
| Cross-kingdom interactions: Candida albicans and bacteria | Q37529923 | ||
| Medically important bacterial-fungal interactions | Q37720396 | ||
| Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance. | Q37869910 | ||
| What's new in the clinical and diagnostic management of invasive candidiasis in critically ill patients | Q38203447 | ||
| The ever-evolving landscape of candidaemia in patients with acute leukaemia: non-susceptibility to caspofungin and multidrug resistance are associated with increased mortality. | Q38412398 | ||
| Tropical healthcare epidemiology: weather determinants of the etiology of bloodstream infections in a Brazilian hospital. | Q39008844 | ||
| Uncommon Candida Species Fungemia among Cancer Patients, Houston, Texas, USA. | Q40942390 | ||
| Mixed species biofilms of Candida albicans and Staphylococcus epidermidis. | Q43942557 | ||
| Acinetobacter is the most common pathogen associated with late-onset and recurrent ventilator-associated pneumonia in an adult intensive care unit in Saudi Arabia | Q44089355 | ||
| A comparison of ventilator-associated pneumonia rates as identified according to the National Healthcare Safety Network and American College of Chest Physicians criteria | Q44112974 | ||
| Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study | Q44352517 | ||
| Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings | Q44936182 | ||
| International study of the prevalence and outcomes of infection in intensive care units | Q44988294 | ||
| Integron-associated imipenem resistance in Acinetobacter baumannii isolated from a regional hospital in Taiwan | Q46855374 | ||
| Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia | Q47653393 | ||
| Candida spp. colonization significance in critically ill medical patients: a prospective study | Q47848695 | ||
| Multidrug resistant Acinetobacter baumannii reaches a new frontier: prosthetic hip joint infection. | Q53498472 | ||
| The Role of Candida sp Isolated From Bronchoscopic Samples in Nonneutropenic Patients | Q57238103 | ||
| Acinetobacter baumannii resistant to everything: what should we do? | Q58386822 | ||
| P433 | issue | 6 | |
| P921 | main subject | Acinetobacter baumannii | Q3241189 |
| ventilator | Q813243 | ||
| risk factor | Q1475848 | ||
| P304 | page(s) | 557-566 | |
| P577 | publication date | 2016-03-21 | |
| P1433 | published in | Medical Mycology | Q6806389 |
| P1476 | title | Candida spp. airway colonization: A potential risk factor for Acinetobacter baumannii ventilator-associated pneumonia | |
| P478 | volume | 54 |
| Q94394679 | Authors' Response |
| Q36933454 | Candida albicans Airway Colonization Facilitates Subsequent Acinetobacter baumannii Pneumonia in a Rat Model. |
| Q40641959 | Clinical predictors and microbiology of ventilator-associated pneumonia in the intensive care unit: a retrospective analysis in six Italian hospitals |
| Q92593802 | Effect of Candida albicans bronchial colonization on hospital-acquired bacterial pneumonia in patients with systemic lupus erythematosus |
| Q90290957 | Impact of bronchial colonization with Candida spp. on the risk of bacterial ventilator-associated pneumonia in the ICU: the FUNGIBACT prospective cohort study |
| Q36340864 | Measuring (1,3)-β-D-glucan in tracheal aspirate, bronchoalveolar lavage fluid, and serum for detection of suspected Candida pneumonia in immunocompromised and critically ill patients: a prospective observational study. |
| Q90176689 | Monoclonal IgM Antibodies Targeting Candida albicans Hyr1 Provide Cross-Kingdom Protection Against Gram-Negative Bacteria |
| Q54215616 | The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection. |
| Q47665567 | Unusually High Incidences of Staphylococcus aureus Infection within Studies of Ventilator Associated Pneumonia Prevention Using Topical Antibiotics: Benchmarking the Evidence Base |
| Q55115354 | World-Wide Variation in Incidence of Staphylococcus aureus Associated Ventilator-Associated Pneumonia: A Meta-Regression. |
| Q28597168 | World-wide variation in incidence of Acinetobacter associated ventilator associated pneumonia: a meta-regression |
Search more.